Increased risk of cardiac conduction abnormalities with ribociclib in patients with metastatic breast cancer: A combined analysis of phase III randomized controlled trials

Somedeb Ball, Sriman Swarup, Anita Sultan, Kyaw Zin Thein

Research output: Contribution to journalArticlepeer-review

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)260-262
Number of pages3
JournalHematology/ Oncology and Stem Cell Therapy
Issue number3
StatePublished - Sep 2021
Externally publishedYes


  • CDK 4/6 inhibitor
  • Meta-analysis
  • QT prolongation
  • Treatment discontinuation

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this